EDWARDS LIFESCIENCES/ US28176E1082 /
13.05.2024 8:08:22 | Изменение -0.84 | Объем сделки | Бид12:33:41 | Предложение12:33:41 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
80.17EUR | -1.04% | 0 Оборот: 0.00 |
79.84Величина цены спроса: 113 | 80.63Величина цены предложения: 112 | 48.51 млрдEUR | - | - |
GlobeNewswire
12:37
MKS Instruments Announces Proposed Private Offering of $1.0 Billion of Convertible Senior Notes
GlobeNewswire
12:30
K92 Mining Announces Strong 2024 Q1 Financial Results – Financial Position Strong as Stage 3 Expansi...
GlobeNewswire
12:30
Ducommun Incorporated Earns Northrop Grumman Missions Systems’ Platinum Supplier Designation
GlobeNewswire
12:05
Federal and State funding award kicks off new growth in Minnesota’s semiconductor industry
GlobeNewswire
12:05
AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update
Newsfile Corp
12:00
KPMG Survey: C-Suite Cyber Leaders Optimistic About Defenses, but Large Percentage Suffered Recent C...
GlobeNewswire
12:00
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...
GlobeNewswire
12:00
Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Adva...
GlobeNewswire
12:00
RadNet, Inc. to Present at the Bank of America Securities 2024 Health Care Conference on May 14th, 2...
GlobeNewswire
12:00
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting ...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница